Press release
Cancer Stem Cells Market Report Evaluates Growth Drivers, Challenges And Market Dynamics
Cancer Stem Cells Market
Projected Expansion and Market Value of the Cancer Stem Cells Market
The cancer stem cells market is anticipated to grow substantially, reaching a valuation of $5.31 billion by 2030. This expansion corresponds to a robust compound annual growth rate (CAGR) of 10.3%. Factors contributing to this rapid growth include the rising demand for long-lasting cancer therapies, increased funding toward targeted oncology research, and the broadening adoption of personalized cancer treatment methods. Additionally, a stronger emphasis on preventing metastasis and integrating cancer stem cell research into clinical oncology practices is accelerating market development. Key trends influencing this landscape involve enhanced focus on therapies targeting resistant cancer cells, advancement in identifying cancer stem cell-specific pathways, development of biomarkers, and growth in translational and clinical research, along with deeper integration of cancer stem cell models for drug discovery processes.
The cancer stem cells market size has grown rapidly in recent years. It will grow from $3.24 billion in 2025 to $3.59 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to advances in stem cell biology research, identification of cancer stem cell populations, growth in oncology research funding, expansion of preclinical cancer models, rising academic-industry collaborations.
Download a free sample of the cancer stem cells market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27235&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Prominent Organizations Leading the Cancer Stem Cells Market
Numerous influential companies are actively shaping the cancer stem cells market. These include MacroGenics Inc., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Lonza Group AG, A. Menarini Industrie Farmaceutiche Riunite S.r.l., Bio-Techne Corporation, Zymeworks Inc., Kura Oncology Inc., GeneTex Inc., YZY Biopharma Co. Ltd., Abnova Taiwan Corporation, BioView Ltd., ScienCell Research Laboratories Inc., Boster Biological Technology Co. Ltd., AAT Bioquest Inc., Celprogen Inc., Actinium Pharmaceuticals Inc., OncoMed Pharmaceuticals Inc., Fate Therapeutics Inc., and Verastem Oncology Inc.
Strategic Acquisitions Enhancing Technological Edge
In March 2023, Canadian nanotechnology and life sciences firm Sona Nanotech Inc. acquired the US-based Siva Therapeutics Inc. for $2 million. This acquisition aims to fast-track the development of Targeted Hyperthermia Therapy (THT) for colorectal cancer by fusing Siva's photothermal treatment platform with Sona Nanotech's proprietary biocompatible gold nanorods. This innovative combination facilitates minimally invasive procedures that boost immune responses, reduce tumors, and optimize drug delivery for various cancer types. Siva Therapeutics specializes in gold nanorod-based photothermal cancer therapies, positioning this collaboration at the forefront of cutting-edge cancer treatment technologies.
View the full cancer stem cells market report:
https://www.thebusinessresearchcompany.com/report/cancer-stem-cells-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Technological Breakthroughs Shaping Cancer Stem Cells Research
Market leaders are increasingly adopting advanced technologies such as pre-analytical immunomagnetic sorting systems to improve the accuracy and efficiency of cancer stem cell isolation. These sophisticated tools use magnetic particles coated with antibodies to selectively extract specific cancer stem cell populations from complex biological samples, enhancing the sensitivity and reproducibility of subsequent tests.
For example, in March 2024, STEMCELL Technologies, a Canadian biotechnology company, introduced the EasySep Human Bone Marrow CD138 Positive Selection Kit. This product is notable as the first hematopoietic cell enrichment kit to receive FDA de novo classification as a Class II in vitro diagnostic device. It allows for the precise enrichment of CD138+ plasma cells from bone marrow samples, improving the detection of abnormalities linked to multiple myeloma. By delivering high-purity cell populations, the kit strengthens the pre-analytical phase of cancer diagnostics and supports more reliable downstream testing, thereby enhancing patient care outcomes.
Core Segments Defining Growth in the Cancer Stem Cells Market
This report categorizes the cancer stem cells market into several key segments:
1) By Type: Solid Tumor Stem Cells, Hematopoietic Stem Cells, Breast Cancer Stem Cells, Colorectal Cancer Stem Cells, Brain Cancer Stem Cells, Leukemia Stem Cells
2) By Cancer Forms: Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, and other cancer types
3) By Mode of Action: Targeted Cancerous Stem Cells (CSCs), Stem Cell-Based Cancer Therapy
4) By Research Type: Basic Research, Clinical Research, Preclinical Research, Translational Research
5) By End User: Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Hospitals and Laboratories, Contract Research Organizations (CROs)
Detailed Subcategories within Major Segments
Further breakdowns include:
- Solid Tumor Stem Cells such as Lung, Liver, Pancreatic, Prostate, and Ovarian cancer stem cells
- Hematopoietic Stem Cells including Myeloid, Lymphoid, Erythroid, Megakaryocytic, and Granulocytic stem cells
- Breast Cancer Stem Cells subdivided into Triple Negative, Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Positive, Metastatic, and Inflammatory breast cancer stem cells
- Colorectal Cancer Stem Cells covering Adenocarcinoma, Mucinous, Signet Ring Cell, Metastatic, and Serrated variants
- Brain Cancer Stem Cells such as Glioblastoma, Medulloblastoma, Astrocytoma, Oligodendroglioma, and Ependymoma stem cells
- Leukemia Stem Cells including Acute Myeloid, Chronic Myeloid, Acute Lymphoblastic, Chronic Lymphocytic, and Mixed Phenotype Acute leukemia stem cells
This comprehensive segmentation offers a detailed landscape of the cancer stem cells market, highlighting its complexity and the diverse avenues for research, development, and commercial opportunities.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Stem Cells Market Report Evaluates Growth Drivers, Challenges And Market Dynamics here
News-ID: 4603952 • Views: …
More Releases from The Business Research Company
Cancer Treatment Facilities Market Study Explores Industry Growth Toward $70.52 …
The cancer treatment facilities market is on track for significant growth over the coming years, driven by advances in medical technology and expanding care options. With a focus on personalized therapies and integrated treatment approaches, the sector is evolving rapidly to meet increasing patient needs. Let's explore how this market is progressing, the key players involved, and the major trends shaping its future.
Projected Expansion of the Cancer Treatment Facilities Market…
Cancer In Vitro Diagnostics (IVD) Market Research Reveals Path To $19.85 Billion …
The cancer in vitro diagnostics (IVD) market is on track for significant expansion over the coming years. Advancements in technology and a growing focus on personalized medicine are driving this sector toward substantial growth, with promising innovations enhancing cancer detection and treatment.
Projected Market Size and Growth of the Cancer In Vitro Diagnostics IVD Market
The cancer in vitro diagnostics (IVD) market is expected to reach $19.85 billion by 2030,…
Cancer Cachexia Market Demonstrates Long-Term Growth Potential At 5.1% CAGR
The cancer cachexia market is on track for significant expansion over the coming years, driven by advancements in treatment approaches and increased focus on patient quality of life. This growing segment of oncology care is attracting attention from pharmaceutical companies and researchers eager to develop more effective therapies for this complex metabolic syndrome. Let's explore the current market size, key players, emerging trends, and segment details shaping the future of…
Calciphylaxis Treatment Market Outlook Signals Expansion To $3.02 Billion Throug …
The calciphylaxis treatment market is on course for notable expansion in the coming years, driven by advancements in medical therapies and a growing commitment to improving patient outcomes. As new treatment methods emerge and healthcare approaches evolve, this sector is poised for significant development and innovation.
Projected Market Size and Growth Path for the Calciphylaxis Treatment Market
The calciphylaxis treatment market is anticipated to expand to $3.03 billion by 2030,…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
